GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
to individuals diagnosed with Parkinson’s Disease or Parkinsonism. YMCA360 offers a vast library of more than 6,000 on-demand videos, which participants can access from any internet-enabled device ...
Negative drug results cost AbbVie billions of dollars in market value and convinced analysts that Bristol Myers had placed a ...
Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...
AbbVie faces setback as schizophrenia trial for emraclidine fails, but still has potential with other assets from Cerevel.
AbbVie in September said another Cerevel drug candidate, tavapadon, met the primary endpoint in a pivotal Phase 3 study in the neurodegenerative disorder Parkinson's disease. AbbVie shares, which hit ...
AbbVie said its recently acquired emraclidine drug candidate for schizophrenia missed the key goal in a pair of mid-stage studies, sending the biopharmaceutical company's shares down more than 10% in ...
The Wisconsin Department of Transportation reported 802 deer-related crashes in Dane County in 2023. WisDOT noted most ...
Front Office Sports on MSN5d
What Donald Trump’s Win Means for Welfare Probe, Brett FavreFavre spoke at Trump’s rally last week in Green Bay, Wis. The post What Donald Trump’s Win Means for Welfare Probe, Brett Favre appeared first on Front Office Sports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback